Start Time: 08:00 January 1, 0000 9:05 AM ET
Bayer Aktiengesellschaft (OTCPK:BAYZF)
Q3 2020 Earnings Conference Call
November 03, 2020, 08:00 AM ET
Company Participants
Werner Baumann - CEO
Wolfgang Nickl - CFO
Stefan Oelrich - President, Pharmaceuticals Division
Liam Condon - President, Crop Science Division
Heiko Schipper - Head of Consumer Health Division
Oliver Maier - Head, IR
Conference Call Participants
Vincent Andrews - Morgan Stanley
Richard Vosser - JPMorgan
Michael Leuchten - UBS
Joel Jackson - BMO Capital Markets
Jo Walton - Credit Suisse
Peter Verdult - Citi
Florent Cespedes - Société Générale
Operator
Ladies and gentlemen, thank you for standing by. Welcome to Bayer's Investor and Analyst Conference Call on the Third Quarter 2020 Results. Throughout today’s recorded presentation, all participants will be in a listen-only mode. The presentation will be followed by a question-and-answer session. [Operator Instructions].
I would now like to turn the conference over to Mr. Oliver Maier, Head of Investor Relations of Bayer AG. Please go ahead, sir.
Oliver Maier
Thank you, Hailey. Good afternoon, and thanks everybody for joining us today for our third quarter 2020 earnings conference call.
With me on the call are Werner Baumann, our CEO; and Wolfgang Nickl, our CFO. The businesses as always are represented by the management Board members who are also on the line. For Crop Science, we have Liam Condon; for Pharma, we have Stefan Oelrich; and for Consumer Health, we have Heiko Schipper.
Werner will begin today's call with an overview of our Group financial performance and the performance of the divisions. Afterwards, Wolfgang will provide more detail on the financials of the third quarter and give a short currency review and present the outlook before we open up for the Q&A session.
As always, I’d like to start by drawing your attention to
- Read more current BAYZF analysis and news
- View all earnings call transcripts